Development of Eco-factors for the European Union based on the Ecological Scarcity Method

The International Journal of Life Cycle Assessment - Weighting as an optional step in life cycle impact assessment (LCIA) has recently gained momentum through increased policy requirements in the...     

Exchange of Cytosolic Content between T Cells and Tumor Cells Activates CD4 T Cells and Impedes Cancer Growth

Background

T cells are known to participate in the response to tumor cells and react with cytotoxicity and cytokine release. At the same time tumors established versatile mechanisms for silencing the immune responses. The interplay is far from being completely understood. In this study we show contacts between tumor cells and lymphocytes revealing novel characteristics in the interaction of T cells and cancer cells in a way not previously described.

Methods/ Findings

Experiments are based on the usage of a hydrophilic fluorescent dye that occurs free in the cytosol and thus transfer of fluorescent cytosol from one cell to the other can be observed using flow cytometry. Tumor cells from cell lines of different origin or primary hepatocellular carcinoma (HCC) cells were incubated with lymphocytes from human and mice. This exposure provoked a contact dependent uptake of tumor derived cytosol by lymphocytes – even in CD4⁺ T cells and murine B cells – which could not be detected after incubation of lymphocytes with healthy cells. The interaction was a direct one, not requiring the presence of accessory cells, but independent of cytotoxicity and TCR engagement.Electron microscopy disclosed 100-200nm large gaps in the cell membranes of connected cells which separated viable and revealed astonishing outcome. While the lymphocytes were induced to proliferate in a long term fashion, the tumor cells underwent a temporary break in cell division. The in vitro results were confirmed in vivo using a murine acute lymphoblastic leukemia (ALL) model. The arrest of tumor proliferation resulted in a significant prolonged survival of challenged mice.

Conclusions

The reported cell-cell contacts reveal new characteristics i.e. the enabling of cytosol flow between the cells including biological active proteins that influence the cell cycle and biological behaviour of the recipient cells. This adds a completely new aspect in tumor induced immunology.     

Expression,Purification and Low-Resolution Structure of Human Vitamin C Transporter SVCT1 (SLC23A1)

Expression and purification of human membrane proteins for structural studies represent a great challenge. This is because micro- to milligram amounts of pure isolated protein are required. To this aim, we successfully expressed the human vitamin C transporter-1 (hSVCT1; SLC23A1) in Xenopus laevis oocytes and isolated highly pure protein in microgram amounts. Recombinant hSVCT1 was functional when expressed in oocytes and glycosylated. Structural analysis of purified hSVCT1 by transmission electron microscopy and single particle analysis unveiled its shape, dimensions and low-resolution structure as well as the existence of a major monomeric and minor dimeric population. Chemical crosslinking of isolated oocyte membranes containing expressed hSVCT1 indicated similar oligomeric states of hSVCT1 in lipid bilayers. This work reports the first purification and structural analysis of a human SVCT protein and opens the way for future functional and structural studies using purified hSVCT1.     

Rice grain zinc concentrations as affected by genotype, native soil-zinc availability, and zinc fertilization

The development of rice (Oryza sativa L.) cultivars with a higher Zn content in their grains has been suggested as a way to alleviate Zn malnutrition in human populations subsisting on rice in their daily diets. This study was conducted to evaluate the effects of native soil Zn status and fertilizer application on Zn concentrations in grains of five rice genotypes that had previously been identified as either high or low in grain Zn. Genotypes were grown in field trials at four sites ranging in native soil-Zn status from severely deficient to high in plant available Zn. At each site a −Zn plot was compared to a +Zn plot fertilized with 15 kg Zn ha⁻¹. Results showed that native soil Zn status was the dominant factor to determine grain Zn concentrations followed by genotype and fertilizer. Depending on soil-Zn status, grain Zn concentrations could range from 8 mg kg⁻¹ to 47 mg kg⁻¹ in a single genotype. This strong location effect will need to be considered in estimating potential benefits of Zn biofortification. Our data furthermore showed that it was not possible to simply compensate for low soil Zn availability by fertilizer applications. In all soils fertilizer Zn was taken up as seen by a 50–200% increase in total plant Zn content. However, in more Zn deficient soils this additional Zn supply improved straw and grain yield and increased straw Zn concentrations by 43–95% but grain Zn concentrations remained largely unchanged with a maximum increase of 6%. Even in soils with high Zn status fertilizer Zn was predominantly stored in vegetative tissue. Genotypic differences in grain Zn concentrations were significant in all but the severely Zn deficient soil, with genotypic means ranging from 11 to 24 mg kg⁻¹ in a Zn deficient soil and from 34 to 46 mg kg⁻¹ in a high Zn upland soil. Rankings of genotypes remained largely unchanged from Zn deficient to high Zn soils, which suggests that developing high Zn cultivars through conventional breeding is feasible for a range of environments. However, it may be a challenge to develop cultivars that respond to Zn fertilizer with higher grain yield and higher grain Zn concentrations when grown in soils with low native Zn status.     

Potential of fecal microbiota for early-stage detection of colorectal cancer

Several bacterial species have been implicated in the development of colorectal carcinoma (CRC), but CRC-associated changes of fecal microbiota and their potential for cancer screening remain to be explored. Here, we used metagenomic sequencing of fecal samples to identify taxonomic markers that distinguished CRC patients from tumor-free controls in a study population of 156 participants. Accuracy of metagenomic CRC detection was similar to the standard fecal occult blood test (FOBT) and when both approaches were combined, sensitivity improved > 45% relative to the FOBT, while maintaining its specificity. Accuracy of metagenomic CRC detection did not differ significantly between early- and late-stage cancer and could be validated in independent patient and control populations (N = 335) from different countries. CRC-associated changes in the fecal microbiome at least partially reflected microbial community composition at the tumor itself, indicating that observed gene pool differences may reveal tumor-related host–microbe interactions. Indeed, we deduced a metabolic shift from fiber degradation in controls to utilization of host carbohydrates and amino acids in CRC patients, accompanied by an increase of lipopolysaccharide metabolism.     

Intracoastal shipping drives patterns of regional population expansion by an invasive marine invertebrate

Understanding the factors contributing to expansion of nonnative populations is a critical step toward accurate risk assessment and effective management of biological invasions. Nevertheless, few studies have attempted explicitly to test hypotheses regarding factors driving invasive spread by seeking correlations between patterns of vector movement and patterns of genetic connectivity. Herein, we describe such an attempt for the invasive tunicate Styela clava in the northeastern Pacific. We utilized microsatellite data to estimate gene flow between samples collected throughout the known range of S. clava in the region, and assessed correlation of these estimates with patterns of intracoastal commercial vessel traffic. Our results suggest that recent shipping patterns have contributed to the contemporary distribution of genetic variation. However, the analysis also indicates that other factors—including a complex invasion history and the influence of other vectors—have partially obscured genetic patterns associated with intracoastal population expansion.     

Synthesis, molecular structure, substitution and C-C coupling reactions of ruthenium complexes containing (η-C9H7)Ru(PPh3) as a molecular unit

The 2-methallyl complex [(η⁵-C₉H₇)Ru(η³-2-MeC₃H₄)(PPh₃)] (3), prepared from [(η⁵-C₉H₇)Ru(PPh₃)₂Cl] (2) and 2-MeC₃H₄MgCl, reacts with HX (X = Cl, CF₃CO₂) in the presence of ethene to give the chiral-at-metal compounds [(η⁵-C₉H₇)Ru(C₂H₄)(PPh₃)X] (4, 5) in nearly quantitative yields. Treatment of 2 with AgPF₆ and ethene affords [(η⁵-C₉H₇)Ru(C₂H₄)(PPh₃)₂]PF₆ (6), which reacts with acetone to give the substitution product [(η⁵-C₉H₇)Ru(OCMe₂)(PPh₃)₂]PF₆ (7). The molecular structure of 7 has been determined crystallographically. Whereas treatment of 4 with CH(CO₂Et)N₂ yields the olefin complex [(η⁵-C₉H₇)Ru{η²-(Z)-C₂H₂(CO₂Et)₂}(PPh₃)Cl] (8), the reactions of 4 and 5 with Ph₂CN₂, PhCHN₂ and (Me₃Si)CHN₂ lead to the formation of the carbeneruthenium(II) derivatives [(η⁵-C₉H₇)Ru(CRR′)(PPh₃)Cl] (9-11) and [(η⁵-C₉H₇)Ru(CRR′)(PPh₃)(κ¹-O₂CCF₃)] (12-14), respectively. Treatment of 9 (R = R′ = Ph), 10 (R = H, R′ = Ph) and 11 (R = H, R′ = SiMe₃) with MeLi produces the hydrido(olefin) complexes [(η⁵-C₉H₇)RuH(η²-CH₂CPh₂)(PPh₃)] (15), [(η⁵-C₉H₇)RuH(η²-CH₂CHPh)(PPh₃)] (18a,b) and [(η⁵-C₉H₇)RuH(η²-CH₂CHSiMe₃)(PPh₃)] (19) via C-C coupling and β-hydride shift. The analogous reactions of 11 with PhLi gives the η³-benzyl compound [(η⁵-C₉H₇)Ru{η³-(Me₃Si)CHC₆H₅}(PPh₃)] (20). The η³-allyl complex [(η⁵-C₉H₇)Ru(η³-1-PhC₃H₄)(PPh₃)] (17) was prepared from 10 and CH₂CHMgBr by nucleophilic attack.     

A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity

Several rabies virus (RV) vaccine strains containing an aspartic acid (Asp) or glutamic acid (Glu) instead of an arginine (Arg) at position 333 of the RV glycoprotein (G) are apathogenic for immunocompetent mice even after intracranial inoculation. However, we previously showed that the nonpathogenic phenotype of the highly attenuated RV strain SPBNGA, which contains a Glu at position 333 of G, is unstable when this virus is passaged in newborn mice. While the Glu(333) remained unchanged after five mouse passages, an Asn(194)-->Lys(194) mutation occurred in RV G. This mutation was associated with increased pathogenicity for adult mice. Using site-directed mutagenesis to exchange Asn(194) with Lys(194) in the G protein of SPBNGA, resulting in SPBNGA-K, we show here that this mutation is solely responsible for the increase in pathogenicity and that the Asn(194)-->Lys(194) mutation does not arise when Asn(194) is exchanged with Ser(194) (SPBNGA-S). Our data presented indicate that the increased pathogenicity of SPBNGA-K is due to increased viral spread in vivo and in vitro, faster internalization of the pathogenic virus into cells, and a shift in the pH threshold for membrane fusion. These results are consistent with the notion that the RV G protein is a major contributor to RV pathogenesis and that the more pathogenic RVs escape the host responses by a faster spread than that of less pathogenic RVs.     

Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development

The mammalian target of rapamycin (mTOR) is a key component of a signaling pathway which integrates inputs from nutrients and growth factors to regulate cell growth. Recent studies demonstrated that mice harboring an ethylnitrosourea-induced mutation in the gene encoding mTOR die at embryonic day 12.5 (E12.5). However, others have shown that the treatment of E4.5 blastocysts with rapamycin blocks trophoblast outgrowth, suggesting that the absence of mTOR should lead to embryonic lethality at an earlier stage. To resolve this discrepancy, we set out to disrupt the mTOR gene and analyze the outcome in both heterozygous and homozygous settings. Heterozygous mTOR (mTOR(+/-)) mice do not display any overt phenotype, although mouse embryonic fibroblasts derived from these mice show a 50% reduction in mTOR protein levels and phosphorylation of S6 kinase 1 T389, a site whose phosphorylation is directly mediated by mTOR. However, S6 phosphorylation, raptor levels, cell size, and cell cycle transit times are not diminished in these cells. In contrast to the situation in mTOR(+/-) mice, embryonic development of homozygous mTOR(-/-) mice appears to be arrested at E5.5; such embryos are severely runted and display an aberrant developmental phenotype. The ability of these embryos to implant corresponds to a limited level of trophoblast outgrowth in vitro, reflecting a maternal mRNA contribution, which has been shown to persist during preimplantation development. Moreover, mTOR(-/-) embryos display a lesion in inner cell mass proliferation, consistent with the inability to establish embryonic stem cells from mTOR(-/-) embryos.